L-alpha-acetylmethadol-induced tissue alterations in mice

Area of Science:

• Pharmacology
• Hepatology
• Toxicology

Background:

• L-alpha-acetylmethadol (LAAM) is a synthetic narcotic analgesic with known physiological effects.
• Glutathione (GSH) plays a crucial role in cellular protection against oxidative stress and xenobiotic metabolism.
• Hepatotoxicity is a potential concern with various pharmaceutical agents.

Purpose of the Study:

• To investigate the effects of L-alpha-acetylmethadol (LAAM) on liver function and glutathione levels in a murine model.
• To determine the dose- and time-dependence of LAAM-induced biochemical and histological changes.
• To evaluate the impact of induced hepatic drug metabolism on LAAM toxicity.

Main Methods:

• Administration of single oral dosages of L-alpha-acetylmethadol (LAAM) to mice.
• Monitoring of serum glutamic-pyruvic transaminase (SGPT) levels and hepatic/renal glutathione (GSH) levels.
• Histological examination of liver tissues.
• Pretreatment with enzyme inducers (phenobarbital, 3-methylcholanthrene) to modulate hepatic metabolism.

Main Results:

• LAAM administration led to elevated SGPT levels and depleted GSH in liver and kidneys.
• LAAM-induced changes were dose- and time-dependent, correlating with mortality.
• Hepatocyte damage (cytoplasmic and nuclear changes) was observed in LAAM-treated mice.
• Induction of hepatic metabolism did not alter LAAM-induced histopathological changes or GSH depletion but reduced mortality and SGPT elevation.

Conclusions:

• LAAM causes significant hepatotoxicity and glutathione depletion in mice.
• The observed toxicity is dose- and time-dependent.
• Modulating hepatic drug metabolism can mitigate some of the acute toxic effects of LAAM, including mortality and transient liver enzyme elevation.